155 related articles for article (PubMed ID: 9209903)
21. The role of prognostic factors and oncogenes in the detection and management of non-small-cell lung cancer.
Van Zandwijk N; Van 't Veer LJ
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):55-9. PubMed ID: 9516613
[TBL] [Abstract][Full Text] [Related]
22. Composite anatomical-clinical-molecular prognostic model in non-small cell lung cancer.
López-Encuentra A; López-Ríos F; Conde E; García-Luján R; Suárez-Gauthier A; Mañes N; Renedo G; Duque-Medina JL; García-Lagarto E; Rami-Porta R; González-Pont G; Astudillo-Pombo J; Maté-Sanz JL; Freixinet J; Romero-Saavedra T; Sánchez-Céspedes M; Gómez de la Camara A;
Eur Respir J; 2011 Jan; 37(1):136-42. PubMed ID: 20817702
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.
Cho A; Hur J; Hong YJ; Lee HJ; Kim YJ; Hong SR; Suh YJ; Im DJ; Kim YJ; Lee JS; Shim HS; Choi BW
Tumour Biol; 2016 Mar; 37(3):3205-13. PubMed ID: 26432331
[TBL] [Abstract][Full Text] [Related]
24. Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010).
Stinchcombe TE; Baggstrom MQ; Somaiah N; Simon GR; Govindan R
J Thorac Oncol; 2011 Jan; 6(1):227-32. PubMed ID: 21178721
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for relapse of resectable pathologic N2 non small lung cancer and prediction model for time-to-progression.
Wen CT; Fu JY; Wu CF; Liu YH; Wu CY; Hsieh MJ; Wu YC; Tsai YH
Biomed J; 2017 Feb; 40(1):55-61. PubMed ID: 28411884
[TBL] [Abstract][Full Text] [Related]
26. [New perspectives in the management of non-small-cell lung carcinoma (NSCLC)].
Brockmöller J; Junker K; Multhoff G
Onkologie; 2006 Sep; 29 Suppl 2():25-8. PubMed ID: 16974125
[No Abstract] [Full Text] [Related]
27. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
[TBL] [Abstract][Full Text] [Related]
28. Hypoxic markers in non-small cell lung cancer (NSCLC) - A review.
Xu FX; Zhang YL; Liu JJ; Zhang DD; Chen HB
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):849-52. PubMed ID: 27010140
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.
Vanhove K; Mesotten L; Heylen M; Derwael R; Louis E; Adriaensens P; Thomeer M; Boellaard R
Cancer Treat Res Commun; 2018; 15():7-12. PubMed ID: 30207286
[TBL] [Abstract][Full Text] [Related]
30. Molecular predictive and prognostic markers in non-small-cell lung cancer.
Coate LE; John T; Tsao MS; Shepherd FA
Lancet Oncol; 2009 Oct; 10(10):1001-10. PubMed ID: 19796752
[TBL] [Abstract][Full Text] [Related]
31. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
33. Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.
Tognela A; Spring KJ; Becker T; Caixeiro NJ; Bray VJ; Yip PY; Chua W; Lim SH; de Souza P
Crit Rev Oncol Hematol; 2015 Feb; 93(2):90-102. PubMed ID: 25459665
[TBL] [Abstract][Full Text] [Related]
34. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers in Non-Small Cell Lung Cancer: Perspectives of Individualized Targeted Therapy.
Aoki MN; Amarante MK; de Oliveira CEC; Watanabe MAE
Anticancer Agents Med Chem; 2018; 18(15):2070-2077. PubMed ID: 30147015
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic indicators in stage I non-small cell lung cancer].
Barlési F; Doddoli C; Greillier L; Astoul P; Giudicelli R; Fuentes P; Thomas P
Rev Mal Respir; 2004 Feb; 21(1):93-103. PubMed ID: 15260042
[TBL] [Abstract][Full Text] [Related]
37. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
[TBL] [Abstract][Full Text] [Related]
38. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.
Osmani L; Askin F; Gabrielson E; Li QK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):103-109. PubMed ID: 29183778
[TBL] [Abstract][Full Text] [Related]
39. Non-small cell lung cancer.
Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Horn L; Jahan TM; Jahanzeb M; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Lennes IT; Loo BW; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Swanson SJ; Wood DE; Yang SC; Hughes M; Gregory KM;
J Natl Compr Canc Netw; 2012 Oct; 10(10):1236-71. PubMed ID: 23054877
[TBL] [Abstract][Full Text] [Related]
40. A new PET/CT volumetric prognostic index for non-small cell lung cancer.
Zhang H; Wroblewski K; Jiang Y; Penney BC; Appelbaum D; Simon CA; Salgia R; Pu Y
Lung Cancer; 2015 Jul; 89(1):43-9. PubMed ID: 25936471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
